Search Results 111-120 of 16370 for Proliferation
Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...
The purpose of this study is to determine changes in proliferation (Ki-67) in ER+HER2-breast cancers that receive turkey tail administration. Testing ...
The purpose of this study is to determine if Lutathera in combination with long-acting octreotide prolongs PFS in GEP-NET patients with high proliferation ...
... proliferation and contributing to cystogenesis. Tissue and Blood Registry for Individuals with Liver and Biliary Tumors. Jacksonville, Fla. This study will ...
Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID). Rochester, Minn., Jacksonville, Fla. The purpose of ...
Renal lesions associated with monoclonal gammopathy of renal significance (MGRS) and hematologic malignancy, including proliferative glomerulonephritis with ...
Diabetes-associated ocular complications assessed in the study included nonproliferative diabetic retinopathy, proliferative diabetic retinopathy, diabetic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.